| UniProt ID | NKAP_HUMAN | |
|---|---|---|
| UniProt AC | Q8N5F7 | |
| Protein Name | NF-kappa-B-activating protein | |
| Gene Name | NKAP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 415 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Acts as a transcriptional repressor. Plays a role as a transcriptional corepressor of the Notch-mediated signaling required for T-cell development. Also involved in the TNF and IL-1 induced NF-kappa-B activation. Associates with chromatin at the Notch-regulated SKP2 promoter.. | |
| Protein Sequence | MAPVSGSRSPDREASGSGGRRRSSSKSPKPSKSARSPRGRRSRSHSCSRSGDRNGLTHQLGGLSQGSRNQSYRSRSRSRSRERPSAPRGIPFASASSSVYYGSYSRPYGSDKPWPSLLDKEREESLRQKRLSERERIGELGAPEVWGLSPKNPEPDSDEHTPVEDEEPKKSTTSASTSEEEKKKKSSRSKERSKKRRKKKSSKRKHKKYSEDSDSDSDSETDSSDEDNKRRAKKAKKKEKKKKHRSKKYKKKRSKKSRKESSDSSSKESQEEFLENPWKDRTKAEEPSDLIGPEAPKTLTSQDDKPLNYGHALLPGEGAAMAEYVKAGKRIPRRGEIGLTSEEIASFECSGYVMSGSRHRRMEAVRLRKENQIYSADEKRALASFNQEERRKRENKILASFREMVYRKTKGKDDK | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 5 | Phosphorylation | ---MAPVSGSRSPDR ---CCCCCCCCCCCC | 29.96 | 23401153 | |
| 7 | Phosphorylation | -MAPVSGSRSPDREA -CCCCCCCCCCCCCC | 23.29 | 23401153 | |
| 9 | Phosphorylation | APVSGSRSPDREASG CCCCCCCCCCCCCCC | 32.61 | 23401153 | |
| 15 | Phosphorylation | RSPDREASGSGGRRR CCCCCCCCCCCCCCC | 28.83 | 23927012 | |
| 17 | Phosphorylation | PDREASGSGGRRRSS CCCCCCCCCCCCCCC | 35.26 | 23927012 | |
| 23 | Phosphorylation | GSGGRRRSSSKSPKP CCCCCCCCCCCCCCC | 36.83 | 28985074 | |
| 24 | Phosphorylation | SGGRRRSSSKSPKPS CCCCCCCCCCCCCCC | 39.72 | 28985074 | |
| 25 | Phosphorylation | GGRRRSSSKSPKPSK CCCCCCCCCCCCCCC | 38.10 | 28985074 | |
| 27 | Phosphorylation | RRRSSSKSPKPSKSA CCCCCCCCCCCCCCC | 39.85 | 33259812 | |
| 31 | Phosphorylation | SSKSPKPSKSARSPR CCCCCCCCCCCCCCC | 45.42 | 30177828 | |
| 33 | Phosphorylation | KSPKPSKSARSPRGR CCCCCCCCCCCCCCC | 33.00 | 20860994 | |
| 46 | Phosphorylation | GRRSRSHSCSRSGDR CCCCCCCCCCCCCCC | 18.29 | - | |
| 50 | Phosphorylation | RSHSCSRSGDRNGLT CCCCCCCCCCCCCCC | 28.84 | 28450419 | |
| 57 | Phosphorylation | SGDRNGLTHQLGGLS CCCCCCCCCCCCCCC | 14.69 | 28450419 | |
| 64 | Phosphorylation | THQLGGLSQGSRNQS CCCCCCCCCCCCCHH | 35.45 | 17525332 | |
| 67 | Phosphorylation | LGGLSQGSRNQSYRS CCCCCCCCCCHHHHH | 22.03 | 28450419 | |
| 78 | Phosphorylation | SYRSRSRSRSRERPS HHHHHHCCCCCCCCC | 35.54 | 20068231 | |
| 80 | Phosphorylation | RSRSRSRSRERPSAP HHHHCCCCCCCCCCC | 39.48 | 20363803 | |
| 85 | Phosphorylation | SRSRERPSAPRGIPF CCCCCCCCCCCCCCC | 58.06 | 23312004 | |
| 94 | Phosphorylation | PRGIPFASASSSVYY CCCCCCCCCCCCEEE | 29.12 | 24144214 | |
| 96 | Phosphorylation | GIPFASASSSVYYGS CCCCCCCCCCEEEEC | 22.20 | 24144214 | |
| 97 | Phosphorylation | IPFASASSSVYYGSY CCCCCCCCCEEEECC | 24.44 | 24144214 | |
| 98 | Phosphorylation | PFASASSSVYYGSYS CCCCCCCCEEEECCC | 16.19 | 24144214 | |
| 100 | Phosphorylation | ASASSSVYYGSYSRP CCCCCCEEEECCCCC | 12.21 | 24144214 | |
| 101 | Phosphorylation | SASSSVYYGSYSRPY CCCCCEEEECCCCCC | 9.46 | 24144214 | |
| 103 | Phosphorylation | SSSVYYGSYSRPYGS CCCEEEECCCCCCCC | 12.10 | 24144214 | |
| 104 | Phosphorylation | SSVYYGSYSRPYGSD CCEEEECCCCCCCCC | 12.34 | 24144214 | |
| 105 | Phosphorylation | SVYYGSYSRPYGSDK CEEEECCCCCCCCCC | 28.60 | 24144214 | |
| 108 | Phosphorylation | YGSYSRPYGSDKPWP EECCCCCCCCCCCCH | 28.31 | 24144214 | |
| 110 | Phosphorylation | SYSRPYGSDKPWPSL CCCCCCCCCCCCHHH | 36.30 | 24144214 | |
| 112 | Acetylation | SRPYGSDKPWPSLLD CCCCCCCCCCHHHCC | 51.16 | 19608861 | |
| 149 | Phosphorylation | APEVWGLSPKNPEPD CCCCCCCCCCCCCCC | 29.86 | 19664994 | |
| 151 | Ubiquitination | EVWGLSPKNPEPDSD CCCCCCCCCCCCCCC | 80.09 | - | |
| 157 | Phosphorylation | PKNPEPDSDEHTPVE CCCCCCCCCCCCCCC | 56.46 | 29255136 | |
| 161 | Phosphorylation | EPDSDEHTPVEDEEP CCCCCCCCCCCCCCC | 27.29 | 29255136 | |
| 171 | Phosphorylation | EDEEPKKSTTSASTS CCCCCCCCCCCCCCC | 42.94 | 28102081 | |
| 172 | Phosphorylation | DEEPKKSTTSASTSE CCCCCCCCCCCCCCH | 33.38 | 28102081 | |
| 173 | Phosphorylation | EEPKKSTTSASTSEE CCCCCCCCCCCCCHH | 29.41 | 28102081 | |
| 174 | Phosphorylation | EPKKSTTSASTSEEE CCCCCCCCCCCCHHH | 21.95 | 28102081 | |
| 176 | Phosphorylation | KKSTTSASTSEEEKK CCCCCCCCCCHHHHH | 32.03 | 28985074 | |
| 177 | Phosphorylation | KSTTSASTSEEEKKK CCCCCCCCCHHHHHH | 39.61 | 30576142 | |
| 178 | Phosphorylation | STTSASTSEEEKKKK CCCCCCCCHHHHHHH | 40.28 | 30576142 | |
| 209 | Phosphorylation | SKRKHKKYSEDSDSD HHHHHHHCCCCCCCC | 23.30 | 30576142 | |
| 210 | Phosphorylation | KRKHKKYSEDSDSDS HHHHHHCCCCCCCCC | 43.75 | 30576142 | |
| 213 | Phosphorylation | HKKYSEDSDSDSDSE HHHCCCCCCCCCCCC | 34.66 | 30576142 | |
| 215 | Phosphorylation | KYSEDSDSDSDSETD HCCCCCCCCCCCCCC | 42.86 | 30576142 | |
| 224 | Phosphorylation | SDSETDSSDEDNKRR CCCCCCCCHHHHHHH | 48.07 | - | |
| 249 | Phosphorylation | KKHRSKKYKKKRSKK HHHHHHHHHHHHHHH | 31.60 | - | |
| 261 | Phosphorylation | SKKSRKESSDSSSKE HHHHHHHCCCCCCHH | 42.34 | 17081983 | |
| 262 | Phosphorylation | KKSRKESSDSSSKES HHHHHHCCCCCCHHH | 42.47 | 17081983 | |
| 264 | Phosphorylation | SRKESSDSSSKESQE HHHHCCCCCCHHHHH | 38.16 | 17081983 | |
| 265 | Phosphorylation | RKESSDSSSKESQEE HHHCCCCCCHHHHHH | 50.88 | 17081983 | |
| 266 | Phosphorylation | KESSDSSSKESQEEF HHCCCCCCHHHHHHH | 44.38 | 17081983 | |
| 269 | Phosphorylation | SDSSSKESQEEFLEN CCCCCHHHHHHHHHC | 46.78 | 17081983 | |
| 280 | Ubiquitination | FLENPWKDRTKAEEP HHHCCCCCCCCCCCC | 60.66 | 24816145 | |
| 282 | Phosphorylation | ENPWKDRTKAEEPSD HCCCCCCCCCCCCHH | 44.75 | 28555341 | |
| 283 | Sumoylation | NPWKDRTKAEEPSDL CCCCCCCCCCCCHHC | 55.48 | - | |
| 283 | Ubiquitination | NPWKDRTKAEEPSDL CCCCCCCCCCCCHHC | 55.48 | - | |
| 283 | Sumoylation | NPWKDRTKAEEPSDL CCCCCCCCCCCCHHC | 55.48 | 28112733 | |
| 298 | Phosphorylation | IGPEAPKTLTSQDDK CCCCCCCCCCCCCCC | 33.92 | 29978859 | |
| 300 | Phosphorylation | PEAPKTLTSQDDKPL CCCCCCCCCCCCCCC | 29.58 | 29978859 | |
| 301 | Phosphorylation | EAPKTLTSQDDKPLN CCCCCCCCCCCCCCC | 34.42 | 28464451 | |
| 305 | Ubiquitination | TLTSQDDKPLNYGHA CCCCCCCCCCCCCCC | 60.74 | 29967540 | |
| 305 | Acetylation | TLTSQDDKPLNYGHA CCCCCCCCCCCCCCC | 60.74 | 26051181 | |
| 305 | Sumoylation | TLTSQDDKPLNYGHA CCCCCCCCCCCCCCC | 60.74 | 28112733 | |
| 309 | Phosphorylation | QDDKPLNYGHALLPG CCCCCCCCCCCCCCC | 20.26 | 29978859 | |
| 324 | Phosphorylation | EGAAMAEYVKAGKRI CHHHHHHHHHCCCCC | 9.56 | 27642862 | |
| 326 | Ubiquitination | AAMAEYVKAGKRIPR HHHHHHHHCCCCCCC | 50.98 | 29967540 | |
| 334 | Methylation | AGKRIPRRGEIGLTS CCCCCCCCCCCCCCH | 41.56 | 115485057 | |
| 352 | Phosphorylation | ASFECSGYVMSGSRH HEEECCEEECCCCHH | 4.08 | - | |
| 355 | Phosphorylation | ECSGYVMSGSRHRRM ECCEEECCCCHHHHH | 24.47 | - | |
| 357 | Phosphorylation | SGYVMSGSRHRRMEA CEEECCCCHHHHHHH | 20.01 | - | |
| 374 | Phosphorylation | LRKENQIYSADEKRA HHHHCCCCCHHHHHH | 6.50 | 30576142 | |
| 375 | Phosphorylation | RKENQIYSADEKRAL HHHCCCCCHHHHHHH | 30.76 | 21815630 | |
| 379 | Ubiquitination | QIYSADEKRALASFN CCCCHHHHHHHHHCC | 43.44 | 24816145 | |
| 400 | Phosphorylation | RENKILASFREMVYR HHHHHHHHHHHHHHH | 22.76 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NKAP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NKAP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NKAP_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-112, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149; SER-157 ANDTHR-161, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-149; SER-261;SER-262; SER-264; SER-265; SER-266 AND SER-269, AND MASS SPECTROMETRY. | |
| "Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-149, AND MASSSPECTROMETRY. | |